3626 results for «568»

Filter By

3626 results

EuroPCR 2021 Hotlines / Late-Breaking Trials in imaging: CASTLE, CLI-OPCI, FORZA, ILUMIEN-IV, CLI-OPCI II, and more!

27 May 2021 – From EuroPCR 2021

Find out more about various studies & registries in imaging:

  • A randomized study comparing imaging guided implantation of Orsiro and Xience: the CASTLE study
  • Impact of different optimal stent implantation definitions in OCT-guide PCI
  • Risk-stratification in ACS by comprehensive morphofunctional assessment with OCT
  • 7.5 years follow-up after OCT-guided PCI: report...
EuroPCR 2021 Hotlines / Late-Breaking Trials in imaging: CASTLE, CLI-OPCI, FORZA, ILUMIEN-IV, CLI-OPCI II, and more!

EuroPCR 2021 Hotlines / Late-Breaking Trials in physiology: FAST II, TARGET FFR, P3, OLV Pullback, France PCI, and more!

27 May 2021 – From EuroPCR 2021

Find out more about various studies & registries in imaging:

  • Angiography based Fractional Flow Reserve: the FAST II trial
  • Instantaneous wave-free ratio for the assessment of nonculprit lesions
  • Capacity of the PPG to predict functional revascularisation
  • Clinical impact of FFR guided PCI
EuroPCR 2021 Hotlines / Late-Breaking Trials in physiology: FAST II, TARGET FFR, P3, OLV Pullback, France PCI, and more!

One-year results from the FUTURE-II trial

19 May 2021 – From EuroPCR 2021

This LBT session, which was originally presented during EuroPCR 2021, deals with the FUTURE-II study on the new generation of bioresorbable scaffolds, providing comparative safety and efficacy evidence of the thinner-strut PLLA-based BRS in the treatment of patients with noncomplex coronary lesions.

One-year results from the FUTURE-II trial

Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction: vascular healing outcomes from the MAGSTEMI trial

27 Dec 2020

The MAGSTEMI trial showed larger endothelium-independent vasodilatation with magnesium-based bioresorbable scaffolds (MgBRS) than with sirolimus-eluting stents (SES). However, restenosis was more frequent with MgBRS. The aims of this study were to compare the healing pattern between MgBRS and SES and to describe the main causes of...

Authors :

J. Gomez-Lara, L. Ortega-Paz, S. Brugaletta, J. Cuesta, S. Romaní, A. Serra, P. Salinas, B. García del Blanco, J. Goicolea, R. Hernandez-Antolín, P. Antuña, R. Romaguera, A. Regueiro, F. Rivero, Àngel Cequier, F. Alfonso, J.Antoni Gómez-Hospital, M. Sabaté
EuroIntervention: BRS versus permanent sirolimus-eluting stents in patients with STEMI: vascular healing outcomes from the MAGSTEMI trial

The impact of COVID-19 pandemic on interventional cardiologists in training

23 Oct 2020

In collaboration with EuroIntervention Journal

The authors decided to create a survey tailored for ICTs in order to assess the changes in their training. Capturing the essence of the responses may help to identify the most appropriate strategies to provide the highest standards and skills achievements in COVID-19...

The impact of COVID-19 pandemic on interventional cardiologists in training

OPTION – Indobufen or aspirin on top of clopidogrel after coronary drug-eluting stent implantation

08 Nov 2022

Ali Nazmi Calik provides his take on OPTION, which was presented during AHA 2022 in Chicago.

Author

Ali Nazmi Calik
OPTION – Indobufen or aspirin on top of clopidogrel after coronary drug-eluting stent implantation
Didn’t find what you were looking for?